Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
Nuplazid Pimavanserin,
ACP-103,
Pimavanserin tartrate
Alzheimer's Disease (Rejected), Schizophrenia (Phase 3), Dementia (Rejected), Depression (Discontinued) Acadia Pharmaceuticals Other Neurotransmitters Small Molecule Parkinson's psychosis